Evidence map›Paper›PMID 36034058›Full record

ArticleWellcome open research2021

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry.

Adeniyi Olagunju, Jacinta Nwogu, Oluwasegun Eniayewu, Shakir Atoyebi, Alieu Amara, John Kpamor, Oluseye Bolaji, Ebunoluwa Adejuyigbe, Andrew Owen, Saye Khoo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Wellcome open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adeniyi OlagunjuDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.ORCID 0000-0002-6588-5749
Jacinta NwoguDepartment of Pharmaceutical Chemistry, University of Ibadan, Ibadan, Nigeria.ORCID 0000-0002-0640-7165
Oluwasegun EniayewuDepartment of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria.
Shakir AtoyebiDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.ORCID 0000-0002-1393-3753
Alieu AmaraDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
John KpamorFederal Medical Centre, Makurdi, Nigeria.
Oluseye BolajiDepartment of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria.ORCID 0000-0002-8295-7150
Ebunoluwa AdejuyigbeDepartment of Paediatrics and Child Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
Andrew OwenDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.ORCID 0000-0002-9819-7651
Saye KhooDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.ORCID 0000-0002-2769-0967

Funding

Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in NigeriaD43TW009608 · FIC · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PHILIP B GORELICK, Olayinka Olusola Omigbodun · 2013 to 2026
$3.9M
FIC NIH HHS D43 TW009608Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cervicovaginal fluidEfavirenzLC-MS/MSPharmacokineticsSwab

Identifiers

PMID36034058
PMCPMC9379332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.